R-268712, CAS [[879487-87-3]]
Artikelnummer:
BYT-ORB1307817
- Bilder (0)
| Artikelname: | R-268712, CAS [[879487-87-3]] |
| Artikelnummer: | BYT-ORB1307817 |
| Hersteller Artikelnummer: | orb1307817 |
| Alternativnummer: | BYT-ORB1307817-1,BYT-ORB1307817-5,BYT-ORB1307817-10,BYT-ORB1307817-25,BYT-ORB1307817-50,BYT-ORB1307817-100,BYT-ORB1307817-200 |
| Hersteller: | Biorbyt |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | renal fibrosis, TGFb, TGF-b/Smad, TGFbeta, TGF-beta, TGF-beta/Smad, TGF-beta Receptor, TGFbeta, TGF-beta, TGF-beta/Smad, TGFbeta/Smad, Smad, R 268712, Thy1 nephritis, R268712, R-268712, Transforming growth factor beta, Transforming growth factor beta receptors, UUO, inhibit, Inhibitor, HFL-1, glomerulonephritis, glomerulosclerosis, Anaplastic lymphoma kinase, Anaplastic lymphoma kinase (ALK), ALK5, ALK tyrosine kinase receptor, CKD, Cluster of differentiation 246, CD246 |
| R-268712 is a potent and orally bioavailable inhibitor of the TGF-beta type I receptor/ALK5, exhibiting an IC50 of 2.5 nM. This small molecule is a valuable research tool for investigating TGF-beta signaling in fibrosis, oncology, and immunology research, applicable in both cellular and animal models. |
| Molekulargewicht: | 363.39 |
| Reinheit: | 99.77% (May vary between batches) |
| CAS Nummer: | [879487-87-3] |
| Formel: | C20H18FN5O |
| Target-Kategorie: | ALK,TGF-beta/Smad |
| Anwendungsbeschreibung: | Solubility: DMSO:250 mg/mL (687.97 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (11.01 mM) |
